Blau Farmacêutica Statistics
Total Valuation
Blau Farmacêutica has a market cap or net worth of BRL 2.48 billion. The enterprise value is 2.65 billion.
Market Cap | 2.48B |
Enterprise Value | 2.65B |
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | Jun 27, 2024 |
Share Statistics
Blau Farmacêutica has 177.68 million shares outstanding. The number of shares has increased by 0.24% in one year.
Shares Outstanding | 177.68M |
Shares Change (YoY) | +0.24% |
Shares Change (QoQ) | -4.01% |
Owned by Insiders (%) | 83.30% |
Owned by Institutions (%) | 5.81% |
Float | 29.68M |
Valuation Ratios
The trailing PE ratio is 11.36 and the forward PE ratio is 10.08. Blau Farmacêutica's PEG ratio is 0.72.
PE Ratio | 11.36 |
Forward PE | 10.08 |
PS Ratio | 1.57 |
PB Ratio | 1.21 |
P/FCF Ratio | 19.77 |
PEG Ratio | 0.72 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.45, with an EV/FCF ratio of 21.17.
EV / Earnings | 12.18 |
EV / Sales | 1.68 |
EV / EBITDA | 7.45 |
EV / EBIT | 8.47 |
EV / FCF | 21.17 |
Financial Position
The company has a current ratio of 3.98, with a Debt / Equity ratio of 27.55.
Current Ratio | 3.98 |
Quick Ratio | 2.59 |
Debt / Equity | 27.55 |
Debt / EBITDA | 1.58 |
Debt / FCF | 4.48 |
Interest Coverage | 5.77 |
Financial Efficiency
Return on equity (ROE) is 10.92% and return on invested capital (ROIC) is 8.30%.
Return on Equity (ROE) | 10.92% |
Return on Assets (ROA) | 6.98% |
Return on Capital (ROIC) | 8.30% |
Revenue Per Employee | 828,897 |
Profits Per Employee | 114,569 |
Employee Count | 1,900 |
Asset Turnover | 0.56 |
Inventory Turnover | 1.91 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.57% in the last 52 weeks. The beta is 0.45, so Blau Farmacêutica's price volatility has been lower than the market average.
Beta (5Y) | 0.45 |
52-Week Price Change | -17.57% |
50-Day Moving Average | 12.21 |
200-Day Moving Average | 12.13 |
Relative Strength Index (RSI) | 59.04 |
Average Volume (20 Days) | 403,450 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Blau Farmacêutica had revenue of BRL 1.57 billion and earned 217.68 million in profits. Earnings per share was 1.23.
Revenue | 1.57B |
Gross Profit | 520.57M |
Operating Income | 312.67M |
Pretax Income | 292.54M |
Net Income | 217.68M |
EBITDA | 350.64M |
EBIT | 312.67M |
Earnings Per Share (EPS) | 1.23 |
Balance Sheet
The company has 376.38 million in cash and 560.39 million in debt, giving a net cash position of -184.01 million or -1.04 per share.
Cash & Cash Equivalents | 376.38M |
Total Debt | 560.39M |
Net Cash | -184.01M |
Net Cash Per Share | -1.04 |
Equity (Book Value) | 2.03B |
Book Value Per Share | 11.50 |
Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was 237.57 million and capital expenditures -112.40 million, giving a free cash flow of 125.17 million.
Operating Cash Flow | 237.57M |
Capital Expenditures | -112.40M |
Free Cash Flow | 125.17M |
FCF Per Share | 0.70 |
Margins
Gross margin is 33.05%, with operating and profit margins of 19.85% and 13.71%.
Gross Margin | 33.05% |
Operating Margin | 19.85% |
Pretax Margin | 18.57% |
Profit Margin | 13.71% |
EBITDA Margin | 22.26% |
EBIT Margin | 19.85% |
FCF Margin | 7.95% |
Dividends & Yields
This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 5.52%.
Dividend Per Share | 0.75 |
Dividend Yield | 5.52% |
Dividend Growth (YoY) | -63.51% |
Years of Dividend Growth | n/a |
Payout Ratio | 26.50% |
Buyback Yield | -0.24% |
Shareholder Yield | 5.28% |
Earnings Yield | 8.80% |
FCF Yield | 5.06% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |